Clinical Trial of TQB2868 Injection in Subjects With Advanced Malignant Tumors

Clinical trial NCT05198505 · UNKNOWN

Trial details

NCT number: NCT05198505
Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Tumor

Start date: 2022-04-27
Primary completion: 2023-06-01
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.